CIC
AZN icon

Chilton Investment Company’s AstraZeneca AZN Stock Holding History

Chilton Investment Company’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$986K Sell
5,268
-16
-0.3% -$3.01K 0.02% 174
2026
Q1 		$1.02M Buy
+5,284
New +$1.02M 0.02% 157

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Chilton Investment Company's AZN Position: Q2 2026 in Review

Chilton Investment Company reduced its AstraZeneca (AZN) stake by 0.3% in Q2 2026, selling an estimated $3.01K and leaving 5,268 shares worth $986K. The position accounts for 0.02% of the portfolio, ranked #174.

Chilton Investment Company first reported a position in AZN in Q1 2026 and has held it in 2 quarters since. The position peaked at $1.02M in Q1 2026. 1,498 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Chilton Investment Company held 5,268 shares of AstraZeneca worth $986K as of Q2 2026.
  • Chilton Investment Company sold 16 AstraZeneca shares in Q2 2026, an estimated $3.01K.
  • AstraZeneca made up 0.02% of Chilton Investment Company's portfolio in Q2 2026, its #174 holding.
  • Chilton Investment Company first reported a position in AstraZeneca in Q1 2026 and has held it in 2 quarters since.
  • Chilton Investment Company's AstraZeneca position peaked at $1.02M in Q1 2026.
  • 1,498 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Chilton Investment Company's 13F filing for Q2 2026, filed 14 Aug 2026.